| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.15 | 0.01 |